Article metrics

Download PDFPDF

Extended report
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

 

Online download statistics by month:

Online download statistics by month: October 2017 to August 2021

AbstractFullPdf
Oct 201722142228493
Nov 201711581206488
Dec 2017593593354
Jan 201812601315426
Feb 2018922955366
Mar 2018642635241
Apr 201860476046195
May 2018684708158
Jun 2018467473189
Jul 2018442442206
Aug 2018429429195
Sep 2018428428199
Oct 2018487496193
Nov 2018606608200
Dec 2018937937203
Jan 2019400388118
Feb 2019404404106
Mar 2019364357111
Apr 2019366346118
May 2019408398140
Jun 2019340338118
Jul 2019363354116
Aug 2019346325116
Sep 201930629690
Oct 2019435425130
Nov 2019304293101
Dec 2019267260118
Jan 2020363344107
Feb 2020309291116
Mar 2020336330105
Apr 2020306298198
May 2020307296235
Jun 2020297278233
Jul 2020311300159
Aug 2020338299124
Sep 2020333300131
Oct 2020258236132
Nov 2020219202107
Dec 202022421088
Jan 202119918884
Feb 2021254232102
Mar 2021447419181
Apr 2021266244111
May 202127826875
Jun 2021230219103
Jul 202117817077
Aug 202121220190
Total27284270088046